Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.08 SEK | -0.30% | +8.15% | +32.91% |
Sales 2024 * | 63.6M 5.82M 465M | Sales 2025 * | 1.2B 110M 8.79B | Capitalization | 1.65B 152M 12.1B |
---|---|---|---|---|---|
Net income 2024 * | -964M -88.26M -7.05B | Net income 2025 * | 511M 46.79M 3.74B | EV / Sales 2024 * | 21 x |
Net cash position 2024 * | 320M 29.25M 2.34B | Net cash position 2025 * | 1.49B 137M 10.92B | EV / Sales 2025 * | 0.13 x |
P/E ratio 2024 * |
-6.4
x | P/E ratio 2025 * |
2.58
x | Employees | 109 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.64% |
Latest transcript on BioInvent International AB
1 day | -0.30% | ||
1 week | +8.15% | ||
Current month | +48.24% | ||
1 month | +47.20% | ||
3 months | +52.91% | ||
6 months | +68.22% | ||
Current year | +32.91% |
Managers | Title | Age | Since |
---|---|---|---|
Martin Welschof
CEO | Chief Executive Officer | 63 | 31/08/18 |
Stefan Ericsson
DFI | Director of Finance/CFO | 61 | 31/12/97 |
Marie Moores
COO | Chief Operating Officer | - | 31/01/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bernd Seizinger
BRD | Director/Board Member | 67 | 31/12/17 |
Leonard Kruimer
CHM | Chairman | 66 | 11/05/16 |
Vincent Ossipow
BRD | Director/Board Member | 55 | 11/05/16 |
Date | Price | Change | Volume |
---|---|---|---|
29/04/24 | 25.2 | +0.20% | 8 988 |
26/04/24 | 25.15 | +1.62% | 46,437 |
25/04/24 | 24.75 | +6.68% | 175,232 |
24/04/24 | 23.2 | -0.85% | 55,571 |
23/04/24 | 23.4 | +0.43% | 32,774 |
Delayed Quote Nasdaq Stockholm, April 29, 2024 at 08:31 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.91% | 151M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+0.76% | 22.15B | |
-17.37% | 21.02B | |
-8.35% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- BINV Stock